5min chapter

AWS Health Innovation Podcast cover image

#56, Alex Zhavoronkov and the GenAI Revolution in Drug Discovery at Insilico Medicine

AWS Health Innovation Podcast

CHAPTER

The Future of Generative AI

In the early stage drug discovery, usually you have to validate experimentally anyway in order for the regulators to give you the green light. So generative is not going to change much because access to your platform, usually people have to apply. It's only available to big pharma and they are not in the business of making bad things happen to humanity. On the clinical and clinical study levels now, I don't think you are going to experience any problems we just need to ensure that the doctors do not also rely on generative systems when filing their reports.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode